rs25487

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006297.3(XRCC1):​c.1196A>G​(p.Gln399Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.658 in 1,613,104 control chromosomes in the GnomAD database, including 351,454 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).

Frequency

Genomes: 𝑓 0.71 ( 39067 hom., cov: 33)
Exomes 𝑓: 0.65 ( 312387 hom. )

Consequence

XRCC1
NM_006297.3 missense

Scores

1
16

Clinical Significance

drug response reviewed by expert panel B:2O:1

Conservation

PhyloP100: 1.98

Publications

1491 publications found
Variant links:
Genes affected
XRCC1 (HGNC:12828): (X-ray repair cross complementing 1) The protein encoded by this gene is involved in the efficient repair of DNA single-strand breaks formed by exposure to ionizing radiation and alkylating agents. This protein interacts with DNA ligase III, polymerase beta and poly (ADP-ribose) polymerase to participate in the base excision repair pathway. It may play a role in DNA processing during meiogenesis and recombination in germ cells. A rare microsatellite polymorphism in this gene is associated with cancer in patients of varying radiosensitivity. [provided by RefSeq, Jul 2008]
XRCC1 Gene-Disease associations (from GenCC):
  • head and neck cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • spinocerebellar ataxia, autosomal recessive 26
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.525281E-7).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.845 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XRCC1NM_006297.3 linkc.1196A>G p.Gln399Arg missense_variant Exon 10 of 17 ENST00000262887.10 NP_006288.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XRCC1ENST00000262887.10 linkc.1196A>G p.Gln399Arg missense_variant Exon 10 of 17 1 NM_006297.3 ENSP00000262887.5
XRCC1ENST00000543982.5 linkc.1103A>G p.Gln368Arg missense_variant Exon 9 of 16 2 ENSP00000443671.1
XRCC1ENST00000597811.5 linkn.*310A>G non_coding_transcript_exon_variant Exon 7 of 7 5 ENSP00000470391.1
XRCC1ENST00000597811.5 linkn.*310A>G 3_prime_UTR_variant Exon 7 of 7 5 ENSP00000470391.1

Frequencies

GnomAD3 genomes
AF:
0.711
AC:
108110
AN:
152018
Hom.:
39012
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.852
Gnomad AMI
AF:
0.590
Gnomad AMR
AF:
0.689
Gnomad ASJ
AF:
0.596
Gnomad EAS
AF:
0.738
Gnomad SAS
AF:
0.652
Gnomad FIN
AF:
0.695
Gnomad MID
AF:
0.734
Gnomad NFE
AF:
0.642
Gnomad OTH
AF:
0.712
GnomAD2 exomes
AF:
0.681
AC:
170473
AN:
250468
AF XY:
0.673
show subpopulations
Gnomad AFR exome
AF:
0.855
Gnomad AMR exome
AF:
0.735
Gnomad ASJ exome
AF:
0.618
Gnomad EAS exome
AF:
0.742
Gnomad FIN exome
AF:
0.688
Gnomad NFE exome
AF:
0.643
Gnomad OTH exome
AF:
0.662
GnomAD4 exome
AF:
0.652
AC:
952451
AN:
1460968
Hom.:
312387
Cov.:
39
AF XY:
0.652
AC XY:
473566
AN XY:
726870
show subpopulations
African (AFR)
AF:
0.857
AC:
28686
AN:
33468
American (AMR)
AF:
0.730
AC:
32640
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.613
AC:
16027
AN:
26128
East Asian (EAS)
AF:
0.741
AC:
29396
AN:
39692
South Asian (SAS)
AF:
0.647
AC:
55826
AN:
86232
European-Finnish (FIN)
AF:
0.691
AC:
36866
AN:
53328
Middle Eastern (MID)
AF:
0.711
AC:
4097
AN:
5764
European-Non Finnish (NFE)
AF:
0.638
AC:
708635
AN:
1111278
Other (OTH)
AF:
0.667
AC:
40278
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
17683
35367
53050
70734
88417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18874
37748
56622
75496
94370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.711
AC:
108216
AN:
152136
Hom.:
39067
Cov.:
33
AF XY:
0.713
AC XY:
53053
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.852
AC:
35385
AN:
41516
American (AMR)
AF:
0.689
AC:
10536
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.596
AC:
2068
AN:
3470
East Asian (EAS)
AF:
0.738
AC:
3815
AN:
5166
South Asian (SAS)
AF:
0.652
AC:
3142
AN:
4820
European-Finnish (FIN)
AF:
0.695
AC:
7359
AN:
10582
Middle Eastern (MID)
AF:
0.735
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
0.642
AC:
43663
AN:
67986
Other (OTH)
AF:
0.710
AC:
1496
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1594
3188
4783
6377
7971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.664
Hom.:
71046
Bravo
AF:
0.719
TwinsUK
AF:
0.626
AC:
2320
ALSPAC
AF:
0.646
AC:
2489
ESP6500AA
AF:
0.845
AC:
3723
ESP6500EA
AF:
0.640
AC:
5501
ExAC
AF:
0.682
AC:
82838
Asia WGS
AF:
0.709
AC:
2466
AN:
3478
EpiCase
AF:
0.648
EpiControl
AF:
0.650

ClinVar

Significance: drug response
Submissions summary: Benign:2Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Spinocerebellar ataxia, autosomal recessive 26 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 31, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21427728, 15113441, 19481337, 11782372, 23479765, 14630517, 21843798, 22053659, 22951806, 24176953, 22224629, 22106831, 23360319, 21987112, 21928248, 18641418, 22193858, 19012493, 22525558, 22712837, 19880550, 22302399, 22983827, 21617750, 20431719, 23499241, 19465687, 20385586, 18357393, 21647176, 19051060, 23055018, 17961713, 22868082, 22568010, 19428062, 11104903, 24205020) -

Platinum compounds response - Efficacy Other:1
Mar 24, 2021
PharmGKB
Significance:drug response
Review Status:reviewed by expert panel
Collection Method:curation

PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Efficacy

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
15
DANN
Benign
0.13
DEOGEN2
Benign
0.0072
.;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.029
.;T
MetaRNN
Benign
6.5e-7
T;T
MetaSVM
Benign
-0.98
T
PhyloP100
2.0
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
2.1
N;N
REVEL
Benign
0.072
Sift
Benign
1.0
T;T
Sift4G
Benign
0.88
T;T
Polyphen
0.0
.;B
Vest4
0.057
MPC
0.23
ClinPred
0.0059
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.15
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs25487; hg19: chr19-44055726; COSMIC: COSV53447249; COSMIC: COSV53447249; API